Progression to colectomy in the era of biologics: A single center experience with pediatric ulcerative colitis

BACKGROUND/PURPOSE: Clinical outcomes in pediatric ulcerative colitis (UC) in the era of biologic agents are poorly defined. We aimed to describe risk factors for colectomy in pediatric UC in the era of infliximab therapy. METHODS: We reviewed 217 pediatric patients at Texas Children’s Hospital with...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:J Pediatr Surg
Autores principales: Ihekweazu, Faith D., Fofanova, Tatiana, Palacios, Ryan, Ajjarapu, Avanthi, Karam, Lina, Vogel, Adam M., Rodriguez, J R, Kellermayer, Richard
Formato: Artigo
Lenguaje:Inglês
Publicado: 2020
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7396289/
https://ncbi.nlm.nih.gov/pubmed/32087936
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jpedsurg.2020.01.054
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares